These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15985728)

  • 1. Indigenous recombinant streptokinase vs natural streptokinase in acute myocardial infarction patients: Phase III multicentric randomized double blind trial.
    Diwedi SK; Hiremath JS; Kerkar PG; Reddy KN; Manjunath CN; Ramesh SS; Prabhavati S; Dhobe M; Singh K; Bhusari P; Rao R
    Indian J Med Sci; 2005 May; 59(5):200-7. PubMed ID: 15985728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction].
    Tomasević M; Kostić T; Apostolović S; Perisić Z; Djordjević-Radojković D; Koraćević G; Salinger-Martinović S
    Srp Arh Celok Lek; 2008; 136(9-10):481-7. PubMed ID: 19069338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of a functional test of neutralising streptokinase antibodies for the prediction of the thrombolytic effect of streptokinase in acute myocardial infarction.
    Gill S; Kristensen SR; Haastrup B; Haghfelt T
    Cardiology; 2003; 100(1):36-40. PubMed ID: 12975544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECG and enzymatic indicators of therapeutic success after intravenous streptokinase for acute myocardial infarction--a pilot study.
    Ahmad I; Ishaq M
    J Pak Med Assoc; 1992 Dec; 42(12):288-90. PubMed ID: 1299734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators.
    Tebbe U; Michels R; Adgey J; Boland J; Caspi A; Charbonnier B; Windeler J; Barth H; Groves R; Hopkins GR; Fennell W; Betriu A; Ruda M; Mlczoch J
    J Am Coll Cardiol; 1998 Mar; 31(3):487-93. PubMed ID: 9502624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
    Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of enoxaparin simultaneously with fibrinolysis in patients with acute myocardial infarction with ST-elevation].
    Despotović N; Loncar G; Nikolić-Despotović M; Ilić M; Dimković S; Mirić M
    Med Pregl; 2009; 62(1-2):13-6. PubMed ID: 19514594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of streptokinase on reperfusion after acute myocardial infarction and its complications: an ex-post facto study.
    Taheri L; Boroujeni AZ; Kargar Jahromi M; Charkhandaz M; Hojat M
    Glob J Health Sci; 2015 Jan; 7(4):184-9. PubMed ID: 25946921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study.
    Simoons M; Krzemiñska-Pakula M; Alonso A; Goodman S; Kali A; Loos U; Gosset F; Louer V; Bigonzi F;
    Eur Heart J; 2002 Aug; 23(16):1282-90. PubMed ID: 12175665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
    Wong CK; French JK; Krucoff MW; Gao W; Aylward PE; White HD
    Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.